Our results demonstrate that global actions of Mxd3 are central to the initiation of obesity in the gMX zebrafish through their effects on adipogenesis and that MXD3 could serve as a therapeutic target for obesity-associated liver diseases. This evidence concerns the gene MXD3 and obesity due to melanocortin 4 receptor deficiency.